NCT01919398View on ClinicalTrials.gov

A Study of LY2940680 in Japanese Participants With Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

June 28, 2017

Conditions
Neoplasm Metastasis
Interventions
DRUG

LY2940680

Administered orally

Trial Locations (2)

411-8777

For additional information regarding investigative sites for this trial, contact 1-858-255-5959 Mon - Fri from 9 AM to 5 PM Pacific Time (PST), or speak with your personal physician., Shizuoka

104-0045

For additional information regarding investigative sites for this trial, contact 1-858-255-5959 Mon - Fri from 9 AM to 5 PM Pacific Time (PST), or speak with your personal physician., Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01919398 - A Study of LY2940680 in Japanese Participants With Advanced Cancers | Biotech Hunter | Biotech Hunter